ID

34303

Description

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD); ODM derived from: https://clinicaltrials.gov/show/NCT01295710

Lien

https://clinicaltrials.gov/show/NCT01295710

Mots-clés

  1. 16/01/2019 16/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility GVHD NCT01295710

Eligibility GVHD NCT01295710

  1. StudyEvent: Eligibility
    1. Eligibility GVHD NCT01295710
Criteria
Description

Criteria

patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
Description

ID.1

Type de données

boolean

patients with an unrelated hla-a,-b, -c and -drbi matched donor
Description

ID.2

Type de données

boolean

patients with a karnofsky performance score ≥ 70%
Description

ID.3

Type de données

boolean

key exclusion criteria:
Description

ID.4

Type de données

boolean

clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
Description

ID.5

Type de données

boolean

bacterial, viral, or fungal infections
Description

ID.6

Type de données

boolean

known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
Description

ID.7

Type de données

boolean

patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
Description

ID.8

Type de données

boolean

known contraindications to the administration of rabbit immunoglobulin antibodies
Description

ID.9

Type de données

boolean

hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
Description

ID.10

Type de données

boolean

Similar models

Eligibility GVHD NCT01295710

  1. StudyEvent: Eligibility
    1. Eligibility GVHD NCT01295710
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
ID.1
Item
patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
boolean
ID.2
Item
patients with an unrelated hla-a,-b, -c and -drbi matched donor
boolean
ID.3
Item
patients with a karnofsky performance score ≥ 70%
boolean
ID.4
Item
key exclusion criteria:
boolean
ID.5
Item
clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
boolean
ID.6
Item
bacterial, viral, or fungal infections
boolean
ID.7
Item
known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
boolean
ID.8
Item
patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
boolean
ID.9
Item
known contraindications to the administration of rabbit immunoglobulin antibodies
boolean
ID.10
Item
hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial